The US Food and Drug Administration (FDA) has advised infant formula producers to tighten supplier oversight after botulism outbursts and a contaminated ingredient triggered recalls in multiple markets. The regulator called on producers and supply chain collaboration to identify where ingredients o...
Cytovance Biologics, an important US-based contract development and manufacturing organization (CDMO) helping the pharmaceutical organization, announced the expansion of its upstream process advancement with the addition of perfusion capabilities. The novel ability offers pharmaceutical organizatio...
Leiutis Pharmaceuticals LLP has announced that the Central Drugs Standard Control Organisation (CDSCO) has granted government support to its collaboration partner, Zenara Pharma, to produce a Synthetic Cannabidiol Oral Solution 150 mg/mL for the management of mild to moderate anxiety disorders, to b...
Evonik is making a noteworthy investment to support production abilities at its Lafayette, Indiana, facility. After completing the next five years, the organization will spend US$100 million to modernize key healthcare devices, including 100 m³ reactors and other critical technologies, to improve r...
Givaudan, the worldwide leader in fragrance and beauty, announced an equity spending and strategic partnering with the Swiss organization Microcaps AG to strengthen its encapsulation capabilities, reinforcing its leadership in fragrance innovation and customer-centric services. Encapsulation techno...
SpudCell is the first artificial cell that can feed, grow, and achieve an entire life cycle. It is made entirely of non-living chemical mechanisms, marking a significant step for synthetic biology, based on a brief. Researchers are referring to the project as “SpudCell”, the name having...
Inside Therapeutics partners with Meiwafosis Co., Ltd. to bring microfluidic nanoparticle formulation technology to scientists in the country, backed by a distributor who knows the local research landscape inside and out. A new step in TAMARA's global expansion Following growing acceptance in Euro...
Peer-Reviewed Studies Confirm Strong Clinical Performance Biocon announced the publication of important clinical data supporting the effectiveness of Yesafili, its biosimilar version of Eylea (aflibercept). The findings were published in two respected peer-reviewed medical journals, providing indep...
Healthcare Entrepreneur Plans a New Phase of Expansion On 12th July 2026, Indian healthcare entrepreneur GSK Velu is preparing for a major milestone in his business journey by planning to list four of his healthcare companies on the stock market over the next three years. The move is expected to un...
Trak Ground Wear launched its first product, TRAK Compression, a zoned compression sock industrialized in collaboration with Dr. Eric Goodman, the chiropractor and mobility specialist who originated Foundation Training. Intended to provision the foot’s natural mechanics rather than inertly squ...
